Hester Biosciences CFO Divyesh Maru resigns effective Nov 13, 2025
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chief Financial Officer and Key Managerial Personnel Mr. Divyesh Maru resigned from Hester Biosciences, effective close of office hours on November 13, 2025, citing personal career interests. He confirmed there are no material reasons other than those stated for his exit. The company acknowledged his contributions during his tenure. No successor has been named in this filing.
Routine CFO departure for personal reasons. May cause short-term uncertainty until a replacement CFO is appointed, but no governance concerns flagged.